An Update on Research on Sepsis (Session 16 – 4th World Sepsis Congress)
Session 16 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:

00:00 Intro
00:38 Flavia Machado – Introduction
01:32 Kusum Menon – Why Criteria for Diagnosing Pediatric Sepsis and the Social Determinants of Health Matter
19:50 Katherine Reitz – Impact of Time to Source Control on Sepsis Mortality
36:13 Hallie Prescott – Does Rapid Sepsis Treatment Increase the Risk of Antimicrobial Resistance?
56:18 François Lamontagne – Intravenous Vitamin C in Sepsis: the LOVIT Study
1:10:20 Naomi Hammond – Balanced Crystalloids or Saline for Sepsis?
1:25:11 Ivor Douglas – Restrictive or Liberal Fluid in Sepsis: the CLOVERS Study
1:42:18 Imrana Malik – Closing Remarks

All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518

Session 15 is already available. This concludes the 4th WSC – thanks for your interest over the last weeks. World Sepsis Congress will return with the 2024 WSC Spotlight in April 2024.

Thanks for watching and sharing.

The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.

Stop Sepsis – Save Lives

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.